Gladstone Institutional Advisory’s DermTech, Inc. Common Stock DMTK Stock Holding History

Gladstone Institutional Advisory’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-12,447	Closed	-$49K	–	699
2022 Q3	$49K	Sell	12,447 -5,400	-30%	-$33.2K	﹤0.01%	621
2022 Q2	$99K	Sell	17,847 -1,825	-9%	-$14.9K	0.01%	624
2022 Q1	$289K	Sell	19,672 -76,942	-80%	-$1.03M	0.02%	557
2021 Q4	$1.53M	Buy	96,614 +4,347	+5%	+$104K	0.12%	220
2021 Q3	$2.96M	Buy	92,267 +8,151	+10%	+$286K	0.29%	93
2021 Q2	$3.5M	Buy	84,116 +2,371	+3%	+$97.4K	0.42%	62
2021 Q1	$4.15M	Buy	+81,745	New	+$4.28M	0.65%	39

Other funds holding DMTK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EPIQ Partners Minneapolis, Minnesota $236M AUM 15.39% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Gladstone Institutional Advisory's DMTK Position: Q4 2022 in Review

Gladstone Institutional Advisory sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2022, closing a stake of 12,447 shares — an estimated $49K sold.

Gladstone Institutional Advisory first reported a position in DMTK in Q1 2021 and held it in 7 quarters. The position peaked at $4.15M in Q1 2021. 94 funds tracked by Wall St. Rank hold DMTK as of Q4 2022.

Gladstone Institutional Advisory reported no remaining DermTech, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Gladstone Institutional Advisory sold 12,447 DermTech, Inc. Common Stock shares in Q4 2022, an estimated $49K.
Gladstone Institutional Advisory first reported a position in DermTech, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
Gladstone Institutional Advisory's DermTech, Inc. Common Stock position peaked at $4.15M in Q1 2021.
94 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2022.

Based on Gladstone Institutional Advisory's 13F filing for Q4 2022, filed 1 Feb 2023.